Arrowhead Research | ARWR - Sales Revenues



Arrowhead Research reported $27.77M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Agios Pharmaceuticals USD 12.45M 3.75M Jun/2025
Alnylam Pharmaceuticals USD 773.69M 179.5M Jun/2025
Arrowhead Research USD 27.77M 514.94M Jun/2025
Incyte USD 1.06B 10M Jun/2025
Ionis Pharmaceuticals USD 452M 320M Jun/2025
Ligand Pharmaceuticals USD 47.63M 2.3M Jun/2025
Merck USD 15.81B 280M Jun/2025
Moderna USD 142M 34M Jun/2025
Novartis USD 14.05B 821M Jun/2025
Sarepta Therapeutics USD 611.09M 163.81M Jun/2025
TG Therapeutics USD 141.1M 21.4M Jun/2025
Ultragenyx Pharmaceutical USD 166.5M 27.21M Jun/2025
Vertex Pharmaceuticals USD 2.96B 190M Jun/2025
Xencor USD 43.61M 10.88M Jun/2025